LQDA

LIQUIDIA CORPORATION

LQDA·53635D202·US·Common Stock·Healthcare - Biotechnology-13D/G

LQDA (LIQUIDIA CORPORATION) is held by 148 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($860.2M), FARALLON CAPITAL MANAGEMENT, L.L.C. ($666.9M), VANGUARD CAPITAL MANAGEMENT LLC ($250.3M). Net institutional sentiment: Bullish.

148
Holders
(7 Elite)
$3.8B
Total Value
74% (156)
Consensus
115 buying - 41 selling
13F: Insider & Congress: Updated regularly
LQDA

Smart Money Verdict

View all
Loading verdict
Held by 148 funds
7 elite

Who's Trading

Source dates: Price Aug 21, 2026 · Insiders Aug 21, 2026 · Activists Aug 14, 2026 · Congress none

InsiderRKRielly-Gauvin KatherineExercise 12K shAug 20, 2026
InsiderRKRielly-Gauvin KatherineSell $1.3MAug 20, 2026
InsiderRKRielly-Gauvin KatherineExercise 7K shAug 20, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
10.8M(+96.5%)$860.2M0.0%+49.26%
51
Decreased
8.4M(-3.4%)$666.9M3.1%+275.32%
0
Increased
3.1M(+7.3%)$250.3M0.0%+95.93%
33
Increased
3M(+61.0%)$241.6M0.0%+77.61%
44
Increased
2.1M(+10.0%)$169.2M0.0%+254.17%
33
Decreased
2M(-12.9%)$158.8M0.0%+133.37%
0
Increased
1.5M(+142.2%)$122.2M0.0%+14.50%
49
Increased
1.3M(+45.2%)$101.1M0.0%+67.77%
41
New
1.2M$96.4M0.3%-13.93%
49
Increased
958,892(+18.1%)$76.5M0.0%+163.30%
35
Increased
816,187(+86.0%)$65.1M0.1%+33.88%
46
Increased
709,063(+22.3%)$56.5M0.0%+221.41%
35
Increased
674,033(+21.0%)$53.7M0.0%+187.56%
35
Increased
658,441(+91.0%)$52.5M0.0%+43.78%
46
Increased
606,558(+192.7%)$48.4M0.0%+13.70%
47
Increased
595,629(+2.3%)$47.5M0.0%+208.98%
30
New
542,131$43.2M0.0%-13.93%
40
Increased
503,774(+6.7%)$40.2M0.0%+97.31%
31
Decreased
471,067(-52.9%)$37.6M0.0%+154.45%
0
Decreased
405,090(-15.9%)$32.3M0.0%+118.77%
0

Showing 1-20 of 157

1 / 8
LQDALQDALIQUIDIA CORPORATION

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used